Suppr超能文献

前庭神经鞘瘤部分切除术后残余肿瘤及面部功能的长期随访

Long-term follow-up of residual tumor and facial function after partial resection of vestibular schwannoma.

作者信息

Ferney A, Ferney T, Lazard A, Schmerber S, Gay E, Quatre R

机构信息

Service d'oto-rhino-laryngologie et de chirurgie cervico-faciale, centre hospitalo-universitaire Grenoble-Alpes, BP 217, 38043 Grenoble cedex 09, France.

École nationale de médecine vétérinaire, sciences et ingénieries de l'alimentation, Oniris, BP 40706, 44307 Nantes cedex 03, France.

出版信息

Eur Ann Otorhinolaryngol Head Neck Dis. 2025 Aug 25. doi: 10.1016/j.anorl.2025.08.003.

Abstract

AIM

This study aimed to assess long-term progression of residual tumor and facial function after primary partial resection of large vestibular schwannoma.

MATERIALS AND METHODS

This retrospective study was performed in a tertiary reference center between January 2008 and December 2021. Patients with vestibular schwannoma exceeding 25mm on the long axis underwent partial tumor resection, leaving a residual fragment, and were followed up for at least 3 years. The residue was confirmed on MRI at 6 months. Facial grade was assessed on the House-Brackmann classification at the immediate postoperative time-point and at 1 year.

RESULTS

Fifty-seven patients were included: 10 (17%) showed tumor regrowth, at a mean 53±25.5 months. Forty (70%) showed facial grades≤III at the immediate postoperative time, and 51 (89%) at 1 year. Mean residual tumor size was 13.6±7.2mm in patients with regrowth and 7.4±5mm in those without (P<0.01). On multivariate analysis, only residual tumor size was significantly associated with regrowth (OR=1.263; 95% CI [1.050-1.677]; P=0.04). ROC analysis identified a 6.5mm threshold for residual tumor size, beyond which risk of regrowth increased, with 90% sensitivity, 53% specificity and 0.78 AUC.

CONCLUSION

Partial resection of large vestibular schwannoma provided satisfactory control and only mild postoperative facial palsy. Small residual tumor size was the main factor for success.

摘要

目的

本研究旨在评估大型前庭神经鞘瘤初次部分切除术后残余肿瘤的长期进展情况及面部功能。

材料与方法

本回顾性研究于2008年1月至2021年12月在一家三级转诊中心进行。长径超过25mm的前庭神经鞘瘤患者接受了部分肿瘤切除术,留下残余肿瘤碎片,并进行了至少3年的随访。术后6个月通过磁共振成像(MRI)确认残余肿瘤情况。在术后即刻及1年时根据House-Brackmann分级评估面部功能等级。

结果

共纳入57例患者:10例(17%)出现肿瘤复发,平均复发时间为53±25.5个月。40例(70%)患者术后即刻面部功能等级≤III级,51例(89%)患者术后1年时面部功能等级≤III级。复发患者的平均残余肿瘤大小为13.6±7.2mm,未复发患者的平均残余肿瘤大小为7.4±5mm(P<0.01)。多因素分析显示,只有残余肿瘤大小与肿瘤复发显著相关(比值比[OR]=1.263;95%置信区间[CI][1.050 - 1.677];P=0.04)。ROC分析确定残余肿瘤大小的阈值为6.5mm,超过该阈值肿瘤复发风险增加,敏感度为90%,特异度为53%,曲线下面积(AUC)为0.78。

结论

大型前庭神经鞘瘤部分切除术能提供满意的肿瘤控制效果,且术后仅有轻度面瘫。残余肿瘤体积小是手术成功的主要因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验